ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Asensus Surgical Inc

Asensus Surgical Inc (ASXC)

0.243
-0.006
(-2.41%)
Closed April 24 4:00PM
0.25
0.007
( 2.88% )
Pre Market: 5:27AM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.25
Bid
-
Ask
-
Volume
1,700
0.00 Day's Range 0.00
0.204 52 Week Range 0.699
Market Cap
Previous Close
0.243
Open
-
Last Trade Time
05:41:18
Financial Volume
-
VWAP
-
Average Volume (3m)
1,654,144
Shares Outstanding
264,316,749
Dividend Yield
-
PE Ratio
-0.81
Earnings Per Share (EPS)
-0.3
Revenue
8.58M
Net Profit
-78.43M

About Asensus Surgical Inc

Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy a... Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. Its single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Wilmington, Delaware, USA
Founded
1970
Asensus Surgical Inc is listed in the Surgical,med Instr,apparatus sector of the American Stock Exchange with ticker ASXC. The last closing price for Asensus Surgical was $0.24. Over the last year, Asensus Surgical shares have traded in a share price range of $ 0.204 to $ 0.699.

Asensus Surgical currently has 264,316,749 shares outstanding. The market capitalization of Asensus Surgical is $63.44 million. Asensus Surgical has a price to earnings ratio (PE ratio) of -0.81.

ASXC Latest News

Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG

RESEARCH TRIANGLE PARK, N.C., April 03, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) (“Asensus” or the “Company”), a medical device company that is digitizing the...

Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter 2023 and Full Year 2023

RESEARCH TRIANGLE PARK, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and...

U.S. Index Futures Rise as Fed’s Dovish Outlook Spurs Positive Investor Sentiment; Oil Prices See Minor Declines

U.S. index futures are showing an uptrend in Thursday’s pre-market, driven by the record close of the three major indexes in the previous session and the more “dovish” stance...

Asensus Surgical, Inc. Schedules Fourth Quarter and Full Year 2023 Financial and Operating Results Conference Call for March 21, 2024

RESEARCH TRIANGLE PARK, N.C., March 15, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and...

Asensus Surgical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

RESEARCH TRIANGLE PARK, N.C., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, Executive Vice President and Chief Financial...

Asensus Surgical Celebrates 1,000 Senhance Cases Completed at Three Global Hospitals

RESEARCH TRIANGLE PARK, N.C., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0004-0.1597444089460.25040.2620.240510600810.24921821CS
40.01436.067034365720.23570.2920.20826007530.26879637CS
12-0.02-7.407407407410.270.320.20816541440.27323004CS
260.0156.38297872340.2350.38010.20415083770.27460782CS
52-0.44-63.7681159420.690.6990.20416629720.32417467CS
156-1.7-87.17948717951.953.750.20428702691.42607397CS
260-3.66-93.60613810743.914.50.20432391441.67231187CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ILAGIntelligent Living Application Group Inc
$ 0.8352
(54.67%)
2.69M
AIREreAlpha Tech Corporation
$ 1.61
(38.79%)
1.35M
CDTXCidara Therapeutics Inc
$ 16.00
(30.19%)
22.21k
MRINMarin Software Incorporated
$ 2.95
(25.00%)
15
CULLCullman Bancorp Inc
$ 12.49
(20.27%)
21
ZAPPZapp Electric Vehicles Group Ltd
$ 2.67
(-31.71%)
605
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.3119
(-26.66%)
593.3k
FBLGraniteShares ETF Trust GraniteShares
$ 20.00
(-25.29%)
81.33k
BPTSBiophytis SA
$ 8.00
(-17.55%)
837
ADTXAditxt Inc
$ 2.02
(-14.77%)
1
SBFMSunshine Biopharma Inc
$ 1.005
(8.06%)
3.25M
ILAGIntelligent Living Application Group Inc
$ 0.8352
(54.67%)
2.69M
NUWENewellis Inc
$ 0.2903
(15.15%)
1.36M
AIREreAlpha Tech Corporation
$ 1.61
(38.79%)
1.35M
SQQQProShares UltraPro Short QQQ
$ 12.115
(2.58%)
1.21M

ASXC Discussion

View Posts
retired early retired early 3 weeks ago
Let her rip. :)
👍️0
Zardiw Zardiw 3 weeks ago
$ASXC - #8KSpy Alert:

8:52 EST

https://www.sec.gov/Archives/edgar/data/876378/000143774924010747/0001437749-24-010747-index.htm



Z
👍️0
Lewrock Lewrock 3 weeks ago
There really wasn’t any other option for this great technology to survive.
👍️0
Lewrock Lewrock 4 months ago
Some signs of life in the 4th Q. Still thinking $35 million is the breakeven point. Also noticed that after this January expiration date, the lowest option strike price is $2.50. I have never seen that happen before so I think it has something to do with a reverse split to get the stock price into compliance.
👍️0
retired early retired early 4 months ago
It's ready to rip, I'd say. :)
👍️0
TrendTrade2016 TrendTrade2016 4 months ago
ASXC...READY FOR 42C COMING OUT OF WEELY PINCH
👍️0
TrendTrade2016 TrendTrade2016 4 months ago
ASXC....ON THE MOVE
👍️0
Lewrock Lewrock 5 months ago
They need to sell out. They have a great product that isn’t selling. Why? Because customers fear they won’t survive.
👍️0
retired early retired early 5 months ago
Does ASXC have a future?
ASXC Stock 12 Months Forecast

Based on 2 Wall Street analysts offering 12 month price targets for Asensus Surgical in the last 3 months. The average price target is $1.50 with a high forecast of $2.00 and a low forecast of $1.00. The average price target represents a 536.67% change from the last price of $0.24. :)
👍️0
retired early retired early 7 months ago
Not a big holder either but I see that the inner circle sees something that we do not. :)
👍️0
Monksdream Monksdream 7 months ago
263 million shares outstanding
A 1 for 10 would reduce it to 26 million shares
Not on the NASDAQ noncompliant list but I suspect it will be soon
👍️0
Lewrock Lewrock 7 months ago
I own very few shares and I am wondering if a reverse split could leave me with no shares. I have not seen any SEC filings lately.
👍️0
Monksdream Monksdream 7 months ago
ASXC new 52 weewk low
👍️0
barnyarddog barnyarddog 8 months ago
.35 https://finance.yahoo.com/news/asensus-surgical-announces-collaboration-nvidia-105500968.html
👍️0
subslover subslover 8 months ago
Asensus Surgical Announces Collaboration with NVIDIA to Enhance Augmented Intelligence Capabilities of the ISU
RESEARCH TRIANGLE PARK, N.C., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced a collaboration with NVIDIA to accelerate the development of Asensus’s Intelligent Surgical Unit™ (ISU™) and improve its ability to deliver novel clinical intelligence to surgeons.

Asensus will utilize a broad suite of NVIDIA tools to enhance the augmented intelligence capabilities of its ISU. Asensus’s ISU is built with NVIDIA accelerated computing technology and has been bringing real-time augmented intelligent features — such as digital tags, 3D measurement, and enhanced camera control — to surgeons since 2021.

“We’re thrilled to collaborate with NVIDIA to enhance the machine vision and image analytics capabilities of the ISU, as well as the processing speed and precision of its augmented intelligence capabilities. Utilizing NVIDIA’s advanced technologies will allow us to further improve the ISU’s augmented intelligence capabilities and the roadmap of our innovative clinical applications,” said Anthony Fernando, Asensus Surgical President and CEO. “Through this collaboration, Asensus is furthering its vision to enhance clinical intelligence in surgery through the use of advanced augmented intelligence tools.”

As part of the collaboration, both companies will have early access to relevant product roadmaps, fostering synergistic development. Furthermore, Asensus and NVIDIA plan to jointly define innovative business models for the development, deployment, and commercialization of digital surgical solutions.

“The healthcare industry, and in particular digital surgery, is becoming one of the largest data generating industries. NVIDIA brings a domain-specific full stack edge AI computing platform, Holoscan, to medtech innovators looking to optimize real-time data and image processing to help solve complex problems and improve surgeon decision-making,” said David Niewolny, Director of Healthcare Business Development at NVIDIA. “As a leading FDA cleared solution in soft-tissue abdominal surgery, Asensus’s ISU is a perfect platform to leverage NVIDIA’s software-defined architecture to accelerate innovation and deliver new products to surgeons faster via software-as-a-medical-device applications.”
👍️0
Triple nickle Triple nickle 9 months ago
Bought a few just going to hold these
👍️0
AJ Freely AJ Freely 9 months ago
$ASXC - Announces $10 Million Registered Direct Offering
Working on closing business combination
w/ KARL STORZ VentureONE Pte. Ltd
Up 10% Pre-Market/ Current Price $0.34
👍️0
kzivann kzivann 1 year ago
Moving up nice and steady.

ASXC
👍️0
kzivann kzivann 1 year ago
More news: Asensus and KARL STORZ to Market the Intelligent Surgical Unit and Co-Develop New Vision and Instrument Platforms

https://ir.asensus.com/news-releases/news-release-details/asensus-and-karl-storz-market-intelligent-surgical-unit-and-co

ASXC
👍️0
kzivann kzivann 1 year ago
News: Collaboration with Google Cloud for Surgery. Interesting.

ASXC
👍️ 2
Lewrock Lewrock 1 year ago
Big day today! CE Mark additional approval. Breakeven seems to be above $35 million a year.
👍️0
HokieHead HokieHead 1 year ago
70s and dumping, lmfao.
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
ASXC...READY FOR 95C
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
ASXC ON THE MOVE
👍️0
Lewrock Lewrock 2 years ago
Cantor Fitzgerald sticks their necks out with an overweight rating and a $1.50 target.
👍️0
Lewrock Lewrock 2 years ago
What level of revenue is needed to reach positive cash flow? I think the number is around $40 million. They have a long way to go!
👍️0
wochsac wochsac 2 years ago
I doubt ASXC will be below $3 much longer
👍️0
wochsac wochsac 2 years ago
might see ASXC robotics on Mars 1 day
👍️0
wochsac wochsac 2 years ago
Lets see a nice GAP UP to $4 tomorrow
👍️0
wochsac wochsac 2 years ago
SUPER BUY ASXC is an understatement
👍️0
EyalCap EyalCap 3 years ago
With placement in Japan and Russia last week we are moving up soon
👍️0
bwrbad bwrbad 3 years ago
SUPER BUY ASXC

Soon their SENHANCE surgical units are going to be in a number of US HOSPITALS side by side with Da Vinci. SENHANCE is the safest most sophisticated Robotic AI AR vision tracking surgical platform developed since Da Vinci came to market some 20 years ago.
👍️0
EyalCap EyalCap 3 years ago
Smells like a buy out will happen here soon if not def a M/A
👍️0
A1stockman A1stockman 3 years ago
Great news
👍️0
MDmojo MDmojo 3 years ago
Lets go!!!!
👍️0
Mindgame Mindgame 3 years ago
Go back to sleep. I am out.
👍️0
Mindgame Mindgame 3 years ago
Time for this puppy to wake up!!!!
👍️0
Frankestin Frankestin 3 years ago
https://www.cnbc.com/2021/06/08/senate-passes-bipartisan-tech-and-manufacturing-bill-aimed-at-china.html
👍️0
diskman diskman 3 years ago
$ASXC added to Russell 3000.

https://content.ftserussell.com/sites/default/files/russell_3000_index_additions_-_2021.pdf
👍️0
ClayTrader ClayTrader 3 years ago
* * $ASXC Video Chart 06-04-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 3 years ago
* * $ASXC Video Chart 06-03-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
weasel4339 weasel4339 3 years ago
Any news?
👍️0
smoke_em smoke_em 3 years ago
Boom!
👍️0
NewbieViewbie NewbieViewbie 3 years ago
Why do you say?
👍️0
smoke_em smoke_em 3 years ago
Holding 30,000 shares here. Big things to come!
👍️0
ClayTrader ClayTrader 3 years ago
* * $ASXC Video Chart 05-26-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 3 years ago
* * $ASXC Video Chart 05-18-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
NewbieViewbie NewbieViewbie 3 years ago
Positive earnings is always good
👍️0
NewbieViewbie NewbieViewbie 3 years ago
Earnings Tuesday... then up to $6 or back to $.60. Any ideas?
👍️0
ClayTrader ClayTrader 3 years ago
* * $ASXC Video Chart 04-27-2021 * *

Link to Video - click here to watch the technical chart video

👍️0

Your Recent History

Delayed Upgrade Clock